Market Cap

Medistim ASA Market Capitalization:

kr3.91 Billion

NOK as of Jan. 1, 2024

US$385.1 Million

business Medistim ASA Company Profile

Medistim ASA Main Stock Listing

OSE: MEDI

Market Capitalization History of Medistim ASA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $192.67 B
Stryker Corporation $113.24 B
Medtronic $111.60 B
Boston Scientific Corporation $85.22 B
Shenzhen Mindray Bio-Medical Electronics Co. Ltd $49.33 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Medistim ASA market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr3.91 B -6.75%
Jan. 1, 2023 kr4.20 B -24.59%
Jan. 1, 2022 kr5.56 B 19.61%
Jan. 1, 2021 kr4.65 B 16.97%
Jan. 1, 2020 kr3.98 B 215.03%
Jan. 1, 2019 kr1.26 B -8.95%
Jan. 1, 2018 kr1.39 B 5.56%
Jan. 1, 2017 kr1.31 B 33.95%
Jan. 1, 2016 kr980.4 M 85.34%
Jan. 1, 2015 kr529.0 M 23.40%
Jan. 1, 2014 kr428.7 M 2.62%
Jan. 1, 2013 kr417.7 M 9.57%
Jan. 1, 2012 kr381.2 M -10.68%
Jan. 1, 2011 kr426.8 M -6.40%
Jan. 1, 2010 kr456.0 M 61.29%
Jan. 1, 2009 kr282.7 M -13.89%
Jan. 1, 2008 kr328.3 M 4.65%
Jan. 1, 2007 kr313.7 M 25.55%
Jan. 1, 2006 kr249.9 M 33.01%
Jan. 1, 2005 kr187.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Medistim ASA Categories

languages Healthcare languages Medical Devices

Stocks & Indices

Medistim ASA has the following listings and related stock indices.


Stock: OSE: MEDI

Stock: FSX: MD1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.